File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Efficacy of lignocaine 2% gel in chalazion surgery

TitleEfficacy of lignocaine 2% gel in chalazion surgery
Authors
Issue Date2003
PublisherBMJ Publishing Group. The Journal's web site is located at http://bjo.bmjjournals.com/
Citation
British Journal Of Ophthalmology, 2003, v. 87 n. 2, p. 157-159 How to Cite?
AbstractBackground/aims: To determine whether topical 2% lignocaine (lidocaine) gel is an effective anaesthetic agent for chalazion surgery. Methods: In a randomised controlled clinical trial, 57 subjects aged 12 years or over requiring incision and curettage for chalazion were recruited over an 8 month period. Patients were randomised into two groups. One group received 1.5 ml of lignocaine 2% injection and the other 1.5 ml of lignocaine 2% gel topically. Standard incision and curettage was then performed. The primary outcome of interest was the total pain experienced during the entire procedure including anaesthetic administration as well as incision and curettage. The pain from the local anaesthetic administration and during incision and curettage was assessed independently using a visual analogue scale (0-100). The sum of these two scores would be the total pain score out of 200. "Fear of injection" score (0-100) was also assessed. Results: There was a statistically significant difference in the mean total pain scores between the injection and the gel groups (95.6 v 57.0) (p <0.001) (α = 0.05) (1 - β = 0.9394). There was a statistically significant difference in the mean scores on "pain of anaesthetic administration" (47.0 v 5.5) (p <0.000). There was no statistically significant differences in the mean scores on "fear of injection" (43.9 v 47.7) (p = 0.668) and "pain during incision and curettage" (48.28 v 51.4) (p=0.679). Conclusions: Lignocaine 2% gel is effective in chalazion surgery especially in lowering the pain caused by anaesthetic administration.
Persistent Identifierhttp://hdl.handle.net/10722/176398
ISSN
2015 Impact Factor: 3.036
2015 SCImago Journal Rankings: 1.873
PubMed Central ID
ISI Accession Number ID
References

 

DC FieldValueLanguage
dc.contributor.authorLi, RTHen_US
dc.contributor.authorLai, JSMen_US
dc.contributor.authorNg, JSKen_US
dc.contributor.authorLaw, RWKen_US
dc.contributor.authorLau, EMCen_US
dc.contributor.authorLam, DSCen_US
dc.date.accessioned2012-11-26T09:11:01Z-
dc.date.available2012-11-26T09:11:01Z-
dc.date.issued2003en_US
dc.identifier.citationBritish Journal Of Ophthalmology, 2003, v. 87 n. 2, p. 157-159en_US
dc.identifier.issn0007-1161en_US
dc.identifier.urihttp://hdl.handle.net/10722/176398-
dc.description.abstractBackground/aims: To determine whether topical 2% lignocaine (lidocaine) gel is an effective anaesthetic agent for chalazion surgery. Methods: In a randomised controlled clinical trial, 57 subjects aged 12 years or over requiring incision and curettage for chalazion were recruited over an 8 month period. Patients were randomised into two groups. One group received 1.5 ml of lignocaine 2% injection and the other 1.5 ml of lignocaine 2% gel topically. Standard incision and curettage was then performed. The primary outcome of interest was the total pain experienced during the entire procedure including anaesthetic administration as well as incision and curettage. The pain from the local anaesthetic administration and during incision and curettage was assessed independently using a visual analogue scale (0-100). The sum of these two scores would be the total pain score out of 200. "Fear of injection" score (0-100) was also assessed. Results: There was a statistically significant difference in the mean total pain scores between the injection and the gel groups (95.6 v 57.0) (p <0.001) (α = 0.05) (1 - β = 0.9394). There was a statistically significant difference in the mean scores on "pain of anaesthetic administration" (47.0 v 5.5) (p <0.000). There was no statistically significant differences in the mean scores on "fear of injection" (43.9 v 47.7) (p = 0.668) and "pain during incision and curettage" (48.28 v 51.4) (p=0.679). Conclusions: Lignocaine 2% gel is effective in chalazion surgery especially in lowering the pain caused by anaesthetic administration.en_US
dc.languageengen_US
dc.publisherBMJ Publishing Group. The Journal's web site is located at http://bjo.bmjjournals.com/en_US
dc.relation.ispartofBritish Journal of Ophthalmologyen_US
dc.subject.meshAdulten_US
dc.subject.meshAnesthetics, Local - Administration & Dosageen_US
dc.subject.meshChalazion - Surgeryen_US
dc.subject.meshEyelids - Surgeryen_US
dc.subject.meshFear - Psychologyen_US
dc.subject.meshFemaleen_US
dc.subject.meshGelsen_US
dc.subject.meshHumansen_US
dc.subject.meshInjections - Psychologyen_US
dc.subject.meshLidocaine - Administration & Dosageen_US
dc.subject.meshMaleen_US
dc.subject.meshPain - Prevention & Controlen_US
dc.titleEfficacy of lignocaine 2% gel in chalazion surgeryen_US
dc.typeArticleen_US
dc.identifier.emailLai, JSM: laism@hku.hken_US
dc.identifier.authorityLai, JSM=rp00295en_US
dc.description.naturelink_to_OA_fulltexten_US
dc.identifier.doi10.1136/bjo.87.2.157en_US
dc.identifier.pmid12543742-
dc.identifier.pmcidPMC1771487-
dc.identifier.scopuseid_2-s2.0-0037309717en_US
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-0037309717&selection=ref&src=s&origin=recordpageen_US
dc.identifier.volume87en_US
dc.identifier.issue2en_US
dc.identifier.spage157en_US
dc.identifier.epage159en_US
dc.identifier.isiWOS:000180695300009-
dc.publisher.placeUnited Kingdomen_US
dc.identifier.scopusauthoridLi, RTH=8054515600en_US
dc.identifier.scopusauthoridLai, JSM=7401939748en_US
dc.identifier.scopusauthoridNg, JSK=7202426163en_US
dc.identifier.scopusauthoridLaw, RWK=7201503302en_US
dc.identifier.scopusauthoridLau, EMC=7103086055en_US
dc.identifier.scopusauthoridLam, DSC=35500200200en_US

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats